Growth Metrics

West Pharmaceutical Services (WST) Current Leases (2019 - 2026)

West Pharmaceutical Services has reported Current Leases over the past 8 years, most recently at $21.4 million for Q1 2026.

  • Quarterly Current Leases fell 1.83% to $21.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Mar 2026, down 1.83% year-over-year, with the annual reading at $22.7 million for FY2025, 26.82% up from the prior year.
  • Current Leases was $21.4 million for Q1 2026 at West Pharmaceutical Services, down from $22.7 million in the prior quarter.
  • Over five years, Current Leases peaked at $22.7 million in Q4 2025 and troughed at $9.8 million in Q1 2022.
  • The 5-year median for Current Leases is $17.9 million (2024), against an average of $17.7 million.
  • Biggest five-year swings in Current Leases: surged 72.04% in 2022 and later fell 1.83% in 2026.
  • Tracing WST's Current Leases over 5 years: stood at $16.0 million in 2022, then rose by 10.62% to $17.7 million in 2023, then grew by 1.13% to $17.9 million in 2024, then rose by 26.82% to $22.7 million in 2025, then decreased by 5.73% to $21.4 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods came in at $21.4 million, $22.7 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.